First Page | Document Content | |
---|---|---|
Date: 2014-01-13 17:41:22Health Food and Drug Administration Pharmaceuticals policy Medicine Food law Dietary supplements United States Public Health Service Paul Offit Good manufacturing practice Federal Food Drug and Cosmetic Act Adverse effect Form FDA 483 | Microsoft Word - MRI_Rebuttal_NYTimes_Article_1-7-14_Final.docxAdd to Reading ListSource URL: www.mineralresourcesint.comDownload Document from Source WebsiteFile Size: 85,25 KBShare Document on Facebook |
Perelman School of Medicine at The University of Pennsylvania Paul A. Offit, MD Office Address:DocID: 1vr9a - View Document | |
Microsoft Word - MRI_Rebuttal_NYTimes_Article_1-7-14_Final.docxDocID: 1r1ru - View Document | |
Microsoft Word - Letter to Paul Offit re MMR booster _10_DocID: 1pk3x - View Document | |
Elizabeth Hart Adelaide, South Australia For the attention of: Dr David Tovey Editor in Chief, The Cochrane Library, and Deputy Chief Executive OfficerDocID: 1oCjt - View Document | |
PDF DocumentDocID: 1gBlK - View Document |